Wednesday, March 29, 2017 1:32:09 PM
at QRCInvestmentGroup.com If you no longer wish to receive any more emails
from us or if you wish to leave our subscriber group, simply click on this
link.
Let me show you how you can make 1,200% on this stock
Dear Subscriber
It’s not every day that there is an opportunity to make substantial upside
while limiting downside in the midst of one of the longest running bull
markets ever.
The majority of “regular” stocks are overpriced and awaiting a correction.
This even holds true for big names like Apple, Google and Microsoft which
are all trading at an all-time high.
This is why I’ve been focusing on small companies, and brought
you EMMD early last month.
At the time of my alert the shares of the company were trading at just 20
cents each.
Today, 2 months later, they’re at almost 4 dollars and every sign is
pointing towards a continued run to $50 in the coming months.
That’s because we caught EMMD just at the right time and that right time to
buy is still upon us.
EMMD’s online travel booking business is booming. The company now runs
several of the most well known websites worldwide including:
CompareHotels . Online
AirlineFlightSearch . Com and
TheHotelGiant . Com
as well as their respective smartphone apps which can be downloaded through
Apple’s and Android’s app store.
Priceline started out much like EMMD, by acquiring small competitors and
their stock used to trade at just a few dollars a share before steadily
going up and reaching almost $1,900 today.
I am not saying that EMMD could go to over $1,000 per share any time soon
but I think that at the rate it’s going we could see the stock easily hit
$50 in the next few months.
Make sure to contact all your friends and tell them to buy EMMD right now,
this is an opportunity they won’t want to miss. You should also buy shares
for your portfolio immediately before it passes $4
Today is going to be hot!
Yours truly,
Ian Phelps
Chief Editor for - QRCInvestmentGroup.com
Let's connect on social!
Copyright © 2017 QRC Investment Group, All rights reserved.
You are receiving this message as you opted to sign up for our newsletter
at QRCInvestmentGroup.com If you no longer wish to receive any more emails
from us or if you wish to leave our subscirber group, simply click on this
link.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM